Switch to:
More From Other Websites
3:09 am Roche Hldg reports Phase III GALLIUM study met primary endpoint ahead of schedule May 27 2016
Genentech’s Gazyva® Showed Superior Progression-Free Survival Compared to Rituxan® in People... May 27 2016
Novartis' CEO Says Company Open To Selling Its $14 Billion Stake In Roche 'If The Opportunity Were... May 25 2016
Novartis willing to sell Roche stake without demanding premium - CEO May 25 2016
Novartis willing to sell Roche stake without demanding premium - CEO May 25 2016
Novartis willing to sell Roche stake without demanding premium - CEO May 25 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant... May 25 2016
Novartis Filing for MabThera Biosimilar Accepted in the EU May 24 2016
Roche Gets Accelerated Approval for Immunotherapy Drug May 19 2016
FDA Approves Roche Immunotherapy for Bladder Cancer May 18 2016
Phase III Study of Genentech’s Alecensa® (Alectinib) Showed Superior Efficacy Versus Crizotinib... May 18 2016
U.S. FDA approves Roche's immunotherapy for bladder cancer May 18 2016
Roche receives FDA Approval for novel PD-L1 biomarker assay May 18 2016
U.S. FDA approves Roche's immunotherapy for bladder cancer May 18 2016
FDA Grants Genentech’s Cancer Immunotherapy TECENTRIQ™ (atezolizumab) Accelerated Approval for... May 18 2016
Roche submits 510 (k) filing to FDA for Treponema pallidum assay to aid clinicians in the diagnosis... May 18 2016
Insulet Shares Swoon on Insurer Decision, but Fair Value Is Unchanged May 11 2016
Roche Announces Direct Sales of Kapa Biosystems NGS Products in Canada May 06 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK